Lesley G C King1, Susanna Bortolusso-Ali2, Colette A Cunningham-Myrie3, Marvin E G Reid4. 1. Sickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies, Mona, Kingston, Jamaica, West Indies. Electronic address: lesley.king@uwimona.edu.jm. 2. Sickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies, Mona, Kingston, Jamaica, West Indies. 3. Department of Community Health and Psychiatry, University of the West Indies, Mona, Kingston, Jamaica, West Indies. 4. Tropical Metabolism Research Unit, Tropical Medicine Research Institute, University of the West Indies, Mona, Kingston, Jamaica, West Indies.
Abstract
OBJECTIVE: To compare mortality in children <5 years of age with sickle cell disease (SCD) in Jamaica, a resource-limited country, diagnosed by newborn screening and managed in a comprehensive care facility, to that of the general population. STUDY DESIGN: The study was carried out at the Sickle Cell Unit in Kingston, Jamaica. We determined the status (dead/alive) at age 5 years in a cohort of 548 children with SCD diagnosed by newborn screening and managed at the Sickle Cell Unit during the period November 1995 to December 2009. The standardized mortality ratio was calculated using World Health Organization life tables for reference mortality. RESULTS: Eight deaths (1.5%) occurred in children <5 years of age during the study period. The mean age at death was 2.0 ± 1.5 years. The overall mortality incidence in children <5 years of age was 3.1 (95% CI 1.6, 6.2) per 1000 person-years with a standardized mortality ratio of 0.52 (95% CI 0.3, 1.0). CONCLUSIONS: Mortality in children <5 years of age with SCD diagnosed at birth and managed at a comprehensive care clinic in Jamaica is equivalent to that of the general population. Children with SCD, a highly vulnerable population, can be effectively managed, even in resource-limited environments.
OBJECTIVE: To compare mortality in children <5 years of age with sickle cell disease (SCD) in Jamaica, a resource-limited country, diagnosed by newborn screening and managed in a comprehensive care facility, to that of the general population. STUDY DESIGN: The study was carried out at the Sickle Cell Unit in Kingston, Jamaica. We determined the status (dead/alive) at age 5 years in a cohort of 548 children with SCD diagnosed by newborn screening and managed at the Sickle Cell Unit during the period November 1995 to December 2009. The standardized mortality ratio was calculated using World Health Organization life tables for reference mortality. RESULTS: Eight deaths (1.5%) occurred in children <5 years of age during the study period. The mean age at death was 2.0 ± 1.5 years. The overall mortality incidence in children <5 years of age was 3.1 (95% CI 1.6, 6.2) per 1000 person-years with a standardized mortality ratio of 0.52 (95% CI 0.3, 1.0). CONCLUSIONS: Mortality in children <5 years of age with SCD diagnosed at birth and managed at a comprehensive care clinic in Jamaica is equivalent to that of the general population. Children with SCD, a highly vulnerable population, can be effectively managed, even in resource-limited environments.
Authors: Léon Tshilolo; George Tomlinson; Thomas N Williams; Brígida Santos; Peter Olupot-Olupot; Adam Lane; Banu Aygun; Susan E Stuber; Teresa S Latham; Patrick T McGann; Russell E Ware Journal: N Engl J Med Date: 2018-12-01 Impact factor: 91.245
Authors: Graham R Serjeant; Nicki Chin; Monika R Asnani; Beryl E Serjeant; Karlene P Mason; Ian R Hambleton; Jennifer M Knight-Madden Journal: PLoS One Date: 2018-03-01 Impact factor: 3.240
Authors: Shelly-Ann Williams; Beneka Browne-Ferdinand; Ynolde Smart; Kristen Morella; Susan G Reed; Julie Kanter Journal: Glob Pediatr Health Date: 2017-11-03
Authors: Monika R Asnani; Damian Francis; Jennifer Knight-Madden; Susan Chang-Lopez; Lesley King; Susan Walker Journal: PLoS One Date: 2021-06-09 Impact factor: 3.240
Authors: Lucio Luzzatto; Bruno P Mmbando; Julie Makani; Furahini Tluway; Abel Makubi; Deogratius Soka; Siana Nkya; Raphael Sangeda; Josephine Mgaya; Stella Rwezaula; Fenella J Kirkham; Christina Kindole; Elisha Osati; Elineema Meda; Robert W Snow; Charles R Newton; David Roberts; Muhsin Aboud; Swee Lay Thein; Sharon E Cox Journal: BMC Hematol Date: 2018-11-14